Skip to main content
. 2019 Dec 18;19:219. doi: 10.1186/s12876-019-1132-8

Table 3.

Body weight and risk factors for metabolic disease changes during the 12-week study

Control(n = 79) ADF(n = 90) TRF(n = 95) P-value
Week 4 Week 12 Week 4 Week 12 Week 4 Week 12 Week 4 Week 12
Body weight (kg) 70.32 ± 6.75 71.77 ± 6.90 70.76 ± 7.76 71.28 ± 7.02 71.31 ± 7.04 71.67 ± 7.37 0.648 0.709
BMI 26.48 ± 1.60 26.64 ± 1.66 25.97 ± 1.75 26.15 ± 1.58 26.48 ± 1.38 26.60 ± 1.46 0.049 0.071
Fat mass (kg) 27.91 ± 3.53 28.01 ± 3.49 27.09 ± 2.52 27.10 ± 2.52 27.36 ± 3.44 27.65 ± 3.34 0.241 0.165
Lean mass (kg) 42.41 ± 7.28 42.71 ± 7.67 43.67 ± 7.61 44.17 ± 7.79 43.96 ± 7.18 44.04 ± 7.47 0.352 0.395
Waist circumference 88.29 ± 4.73 88.54 ± 5.10 88.99 ± 5.20 87.19 ± 4.88 89.70 ± 7.42 87.58 ± 4.39 0.590 0.174
Cholesterol (mg/dL) 4.45 ± 1.36 4.65 ± 1.36 3.95 ± 1.08 4.15 ± 1.06 4.03 ± 1.55 4.37 ± 1.53 0.039 0.055
Total Direct HDL(mg/dL) 1.29 ± 0.55 1.18 ± 0.51 1.28 ± 0.41 1.17 ± 0.38 1.18 ± 0.47 1.15 ± 0.45 0.206 0.920
LDL (mg/dL) 2.55 ± 0.79 2.51 ± 0.76 2.82 ± 0.85 2.79 ± 0.83 2.73 ± 0.88 2.71 ± 0.87 0.101 0.085
Triglycerides (mg/dL) 2.28 ± 1.70 2.40 ± 1.70 2.21 ± 1.91 2.12 ± 1.90 2.27 ± 1.75 2.31 ± 1.75 0.965 0.582
Glucose (mg/dL) 5.18 ± 0.072 4.94 ± 1.22 5.36 ± 1.32 5.19 ± 0.67 5.21 ± 1.06 5.05 ± 1.35 0.500 0.355
Liver stiffness (kpa) 18.39 ± 4.64 18.36 ± 3.84 18.03 ± 2.25 18.05 ± 2.84 18.13 ± 4.11 18.37 ± 3.65 0.825 0.766